GOP Senator Wants Time Frame And Other Details On FDA’s AI/ML Action Plan

US Sen. Bill Cassidy says he wants more details about the FDA’s plans to regulate AI/ML medical software, including a time frame for publishing guidance documents.

A sign outside Louisiana Republican senator Bill Cassidy's office in Washington DC.
Sen. Bill Cassidy, R-LA, sent CDRH director Jeff Shuren a letter 10 February asking for more details on FDA's AI/ML SaMD regulatory plans (Shutterstock)

Sen. Bill Cassidy lauded the US Food and Drug Administration for its recently released artificial intelligence and machine learning software action plan, but seems to be pressing the agency step up the pace with a list of pointed questions.

The FDA’s Center for Devices and Radiological Health (CDRH) published last month a five-point action plan on how it wants...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from AI

More from Digital Technologies

Aneira Health Launches New Precision Medicine Platform Exclusively For Women

 

Cecilia Lindgren, Aneira Health’s co-founder and chief science officer, said that the company has “redesigned the diagnostic model.” The subscription-based platform offers clinical-grade and AI diagnostics alongside clinical consultation.

AI In Health Delivery: Patients Most Confident When HCPs Are In Charge

 
• By 

Annual survey of patients and professionals shows how attitudes to health system transformation are evolving and what stakeholders are demanding as acceptance of AI tools accelerates.

Ultrahuman Launches Home Health Monitoring

 

Ultrahuman seeks to “create an environment that aligns with our bodies" by linking environmental parameters collected by Ultrahuman Home to health physiology, measured by the Ultrahuman Ring Air.